Annual Congress Vienna 2012

---

---

Genetics and genomics in asthma and COPD: prediction and personalised medicine

Symposium
Chairs: H. M. Boezen (Groningen, The Netherlands), V. Schluenssen (Arhus, Denmark)
Aims: The audience will take away from this symposium an understanding of:
- the (im)possibility of using genomics and genetics to predict the efficacy of asthma/COPD treatment;
- the applicability of personalised medicine;
- the predictive value of genetic profiling from a methodological perspective;
- issues around psychological, behavioural and ethical aspects of genetic testing;
- the value of genetics compared to phenotypic and environmental factors in asthma and COPD;
- how current knowledge on primarly hereditary risk factors for asthma and other lung diseases improve prevention, treatment and prognosis of asthma.

Predictive and personalised medicine for asthma using genomics S. Weiss (Boston, United States of America)
Genome-based risk prediction of asthma and COPD: applicability and psychological issues C. Janssens (Rotterdam, Netherlands)
Genotype, phenotype and the environment in respiratory diseases: what contributes the most? I. Wouters (Utrecht, Netherlands)
How does current knowledge on primarily hereditary risk factors for asthma and other lung diseases improve prevention, treatment and prognosis? D.S. Postma (Groningen, The Netherlands)